High Intensity Interval Training vs Moderate Intensity and Continuous Training in Chronic Heart Failure
HRVFIT2
Efficacy of High Intensity Interval Training vs Moderate Intensity and Continuous Training on Autonomic Nervous System Modulations in Chronic Heart Failure
1 other identifier
interventional
32
0 countries
N/A
Brief Summary
Purpose: Exaggerated sympathetic nervous system (SNS) activity associated with low heart rate variability (HRV) is considered as a trigger of cardiac arrhythmias and sudden death. Regular exercise training is efficient to improve autonomic balance. In 2013, the investigators published that a single session of an optimized short-high intensity interval exercise with passive recovery (HIIT) protocol was efficient in chronic heart failure (CHF) patients for enhancing vagal tone and to decrease arrhythmias in the 24-h post exercise period when compared to a single session of moderate intensity continuous exercise (MICT). Nevertheless the effects of HIIT training performed on several weeks have never yet been studied on the parameters described by Coumel's triangle (the arrhythmogenic substrate, the trigger factor as premature ventricular contraction and the modulation factors of which the most common is the autonomic nervous system). The aim of this study was to verify the superiority of HIIT to enhance parasympathetic activity, cardiorespiratory fitness and cardiac function when compared to MICT in a short and intense cardiac rehabilitation program.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2015
Typical duration for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 7, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 13, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
October 13, 2017
CompletedFirst Submitted
Initial submission to the registry
July 13, 2018
CompletedFirst Posted
Study publicly available on registry
July 27, 2018
CompletedJuly 30, 2018
July 1, 2018
2.4 years
July 13, 2018
July 27, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
High Frequency power in normalized units (HFnu%)
based on Heart Rate Variability, the power spectral density of the HF (0.15-0.40 Hz, ms2.Hz-1) bands were calculated.
Change from baseline through study completion, an average of 4 weeks (measured during the night period for stationary signal)
Secondary Outcomes (6)
maximal oxygen consumption (VO2peak ml.min.kg)
Change from baseline through study completion, an average of 4 weeks
First ventilatory threshold (VT1) (ml.min.kg)
Change from baseline through study completion, an average of 4 weeks
Heart Rate Recovery (beats per minute, bpm)
Change from baseline through study completion, an average of 4 weeks
Left Ventricular Ejection Fraction (LVEF, %)
Change from baseline through study completion, an average of 4 weeks
premature ventricular contraction, (n/24h)
Change from baseline through study completion, an average of 4 weeks
- +1 more secondary outcomes
Study Arms (2)
high intensity interval training
EXPERIMENTALhigh intensity interval training: two sets of 8-min intervals at 100% of peak power output (PPO). Each interval set was composed of repeated bouts of 30 s at 100% of PPO interspersed by 30 s of passive recovery in the seated position. Four minutes of passive recovery were allowed between the two sets.
moderate intensity and continuous exercise
ACTIVE COMPARATORmoderate intensity and continuous exercise: 30 minutes at 60% of PPO.
Interventions
to compare MICT vs HIIT 5 days/week during 4 weeks in a Cardiovascular Centre.
Eligibility Criteria
You may qualify if:
- stable chronic heart failure with NYHA functional class from I to III
- stable left ventricular ejection fraction (LVEF) \< 45% over at least 6 months
- stable optimal medical therapy including a beta-blocker and an angiotensin-converting enzyme inhibitor or angiotensin receptor blockers for at least 6 weeks
- ability to perform a maximal cardiopulmonary exercise test
- admitted to the Rehabilitation Centre for a comprehensive Cardiovascular Rehabilitation Program
You may not qualify if:
- any relative or absolute contraindications to exercise training according to current recommendations
- fixed-rate pacemaker with heart rate limits set lower than exercise training target
- major cardiovascular event or procedure within the 3 months preceding enrolment
- chronic atrial fibrillation
- heart failure secondary to significant uncorrected primary valve disease (except for mitral regurgitation secondary to left ventricular dysfunction)
- heart failure secondary to congenital heart disease or obstructive cardiomyopathy.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (1)
Besnier F, Labrunee M, Richard L, Faggianelli F, Kerros H, Soukarie L, Bousquet M, Garcia JL, Pathak A, Gales C, Guiraud T, Senard JM. Short-term effects of a 3-week interval training program on heart rate variability in chronic heart failure. A randomised controlled trial. Ann Phys Rehabil Med. 2019 Sep;62(5):321-328. doi: 10.1016/j.rehab.2019.06.013. Epub 2019 Jul 25.
PMID: 31352063DERIVED
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Lisa Richard, MD
Clinic of Saint-Orens, Cardiovascular and Pulmonary Rehabilitation Center, Saint-Orens-de-Gameville, France
- STUDY DIRECTOR
Thibaut Guiraud, PhD
Institute of Cardiovascular and Metabolic Diseases, National Institute of Health and Medical Research (INSERM), UMR-1048, Toulouse, France
- STUDY CHAIR
Florent Besnier, PhD
Clinic of Saint-Orens, Cardiovascular and Pulmonary Rehabilitation Center, Saint-Orens-de-Gameville, France. / Institute of Cardiovascular and Metabolic Diseases, National Institute of Health and Medical Research (INSERM), UMR-1048, Toulouse, France
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- heart rate variability analyses and echocardiography were performed by investigators blind to randomization
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator, Cardiologist
Study Record Dates
First Submitted
July 13, 2018
First Posted
July 27, 2018
Study Start
May 7, 2015
Primary Completion
October 13, 2017
Study Completion
October 13, 2017
Last Updated
July 30, 2018
Record last verified: 2018-07
Data Sharing
- IPD Sharing
- Will not share